Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATx201 Ointment in Mild to Moderate Atopic Dermatitis
2019-002771-33Phase 2Terminated
- Sponsor
- UNION therapeutics
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing ATx201 Ointment with Vehicle Control (2 arms). Primary endpoint: EASI mean change from baseline at Week 6. Started Jul 2019; status: terminated.
02
Drugs
niclosamide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2019-002771-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002771-33.